|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Pap and Antibody ScreenFrom: John Hellriegel (jhellrie@pce.net)Tue Dec 31 16:18:25 1996
Dear List : Ina recept paper (I think the green journal) several authors concluted that a PAP Smear is not cost-effective as a routine screening in women with no uterus (post- TAH) except in the cases that the TAH was done for CA reazons...I agree and start with this practice... Some of my local collegues aren't agree whit this and we have some local debate about this topics.... What about this practice? Do you continue the PAP screening in those cases... Reply: Probably not cost effective, but I have been alerted to several cases of vaginal dysplasia - less than 30 - and one vaginal cancer over the last 20 years. (Recent vaginal dysplasias have been tested for and were positive for HPV.) ------------- And talking abouth cost-effective... I don't found any background for asking for "antibodies" as a routine in a rH positive pregnant women with no obstetrics history of IUD and I don't do it.. Am I wrong? Reply: I have all pregnant patients tested for antibodies - antibody screen. Occasionally (rarely) find antibodies such Kell and Duffy which can affect the fetus. I think an antibody screen is important.
-- John Hellriegel, Jr., MD, PhD Buffalo, NY jhellrie@pce.net
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:20:21 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.